Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease

Author:

Agha Golareh1,Mendelson Michael M.234,Ward-Caviness Cavin K.56,Joehanes Roby27,Huan TianXiao8,Gondalia Rahul9,Salfati Elias10,Brody Jennifer A.11,Fiorito Giovanni12,Bressler Jan13,Chen Brian H.14,Ligthart Symen15,Guarrera Simonetta12,Colicino Elena16,Just Allan C.16,Wahl Simone17,Gieger Christian17,Vandiver Amy R.18,Tanaka Toshiko14,Hernandez Dena G.19,Pilling Luke C.20,Singleton Andrew B.19,Sacerdote Carlotta21,Krogh Vittorio22,Panico Salvatore23,Tumino Rosario24,Li Yun25,Zhang Guosheng26,Stewart James D.27,Floyd James S.11,Wiggins Kerri L.11,Rotter Jerome I.28,Multhaup Michael18,Bakulski Kelly29,Horvath Steven30,Tsao Philip S.10,Absher Devin M.31,Vokonas Pantel32,Hirschhorn Joel3334,Fallin M. Daniele35,Liu Chunyu36,Bandinelli Stefania37,Boerwinkle Eric3839,Dehghan Abbas40,Schwartz Joel D.41,Psaty Bruce M.4243,Feinberg Andrew P.44,Hou Lifang45,Ferrucci Luigi46,Sotoodehnia Nona47,Matullo Giuseppe12,Peters Annette4849,Fornage Myriam50,Assimes Themistocles L.51,Whitsel Eric A.52,Levy Daniel23,Baccarelli Andrea A.1

Affiliation:

1. Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York (G.A., A.A.B.).

2. Population Sciences Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD (M.M.M., D.L., R.J.).

3. Framingham Heart Study, MA (M.M.M., D.L.).

4. Department of Cardiology, Boston Children’s Hospital, MA (M.M.M.).

5. National Health and Environmental Effects Research Laboratory, Environmental Public Health Division, Chapel Hill, NC (C.K.W.C.).

6. Institute of Epidemiology II, Helmholtz Institute, Ingolstaedter Landstrasse 1, Neuherberg, Germany (C.K.W.C.).

7. Hebrew SeniorLife, Harvard Medical School, Boston, MA (R.J.).

8. The Population Sciences Branch, Division of Intramural Research, National Heart, Lung and Blood Institute, Bethesda, MD (T.X.H.).

9. Department of Epidemiology (R.G.), University of North Carolina, Chapel Hill.

10. Department of Medicine, Stanford University School of Medicine, CA (E.S., P.S.T.).

11. Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle (J.A.B., J.S.F., K.L.W.).

12. Italian Institute for Genomic Medicine (IIGM/HuGeF) and Department of Medical Sciences, University of Turin, Italy (G.F., S.G., G.M.).

13. Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston (J.B.).

14. Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD (B.H.C., T.T.).

15. Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands (S.L.).

16. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY (E.C., A.C.J.).

17. Research Unit Molecualr Epidemiology, Helmholtz Zentrum München, Germany (S.W., C.G.).

18. Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD (A.R.V., M.M.).

19. Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD (D.G.H., A.B.S.).

20. Epidemiology and Public Health Group, University of Exeter Medical School, United Kingdom (L.C.P.).

21. Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy (C.S.).

22. Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (V.K.).

23. Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy (S.P.).

24. Cancer Registry And Histopathology Department, Civic- M.P. Arezzo2 Hospital, Asp Ragusa, Italy (R.T.).

25. Department of Genetics, Department of Biostatistics, Department of Computer Science (Y.L.), University of North Carolina, Chapel Hill.

26. Curriculum in Bioinformatics and Computational Biology, Department of Genetics, and Department of Statistics (G.Z.), University of North Carolina, Chapel Hill.

27. Carolina Population Center and Department of Epidemiology (J.D.S.), University of North Carolina, Chapel Hill.

28. The Institute for Translational Genomics and Population Sciences, Departments of Pediatrics and Medicine, LABioMed at Harbor-UCLA Medical Center, Torrance, CA (J.I.R.).

29. Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (K.B.).

30. Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles (S.H.).

31. HudsonAlpha institute of Biotechnology, Huntsville, AL (D.M.A.).

32. VA Normative Aging Study, VA Boston Healthcare System, Department of Medicine, Boston University School of Medicine, MA (P.V.).

33. Department of Medicine, Division of Endocrinology, Boston Children’s Hospital, MA (J.H.).

34. Departments of Medicine and Pediatrics, Harvard Medical School, Boston, MA (J.H.).

35. Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (M.D.F.).

36. Department of Biostatistics, Boston University School of Public Health, MA (C.L.).

37. Azienda Sanitaria, USL Centro Firenze, Italy (S.B.).

38. Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston (E.B.).

39. Human Genome Sequencing Center, Baylor College of Medicine, TX (E.B.).

40. Department of Epidemiology and Biostatistics, MRC–PHE Centre for Environment & Health, School of 346 Public Health, Imperial College London, United Kingdom (A.D.).

41. Department of Epidemiology and Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA (J.D.S.).

42. Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services, University of Washington, Seattle (B.M.P.).

43. Kaiser Permanente Washington Health Research Institute, Seattle (B.M.P.).

44. Departments of Medicine, Biomedical Engineering, and Mental Health, Johns Hopkins University, Baltimore, MD (A.P.F.).

45. Center for Population Epigenetics, Robert H. Lurie Comprehensive Cancer Center and Department of Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL (L.H.).

46. Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD (L.F.).

47. Division of Cardiology, Departments of Medicine and Epidemiology, Cardiovascular Health Research Unit, University of Washington, Seattle (N.S.).

48. Helmholtz Zentrum München, Institute of Epidemiology, Neuherberg, Germany; German Research Center for Cardiovascular Disease (DzHK e.V. - partner site Munich), Germany (A.P.).

49. Ludwig-Maximilians University, Institute for Biometry, Medical Information Science and Epidemiology, Munich, Germany (A.P.).

50. Brown Foundation Institute of Molecular Medicine McGovern Medical School, and Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston (M.F.).

51. Department of Medicine (Cardiovascular Medicine), and Department of Health Research & Policy, Stanford University School of Medicine, CA (T.L.A.).

52. Department of Epidemiology, Gillings School of Global Public Health, and Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill (E.A.W.).

Abstract

Background: DNA methylation is implicated in coronary heart disease (CHD), but current evidence is based on small, cross-sectional studies. We examined blood DNA methylation in relation to incident CHD across multiple prospective cohorts. Methods: Nine population-based cohorts from the United States and Europe profiled epigenome-wide blood leukocyte DNA methylation using the Illumina Infinium 450k microarray, and prospectively ascertained CHD events including coronary insufficiency/unstable angina, recognized myocardial infarction, coronary revascularization, and coronary death. Cohorts conducted race-specific analyses adjusted for age, sex, smoking, education, body mass index, blood cell type proportions, and technical variables. We conducted fixed-effect meta-analyses across cohorts. Results: Among 11 461 individuals (mean age 64 years, 67% women, 35% African American) free of CHD at baseline, 1895 developed CHD during a mean follow-up of 11.2 years. Methylation levels at 52 CpG (cytosine-phosphate-guanine) sites were associated with incident CHD or myocardial infarction (false discovery rate<0.05). These CpGs map to genes with key roles in calcium regulation (ATP2B2, CASR, GUCA1B, HPCAL1), and genes identified in genome- and epigenome-wide studies of serum calcium (CASR), serum calcium-related risk of CHD (CASR), coronary artery calcified plaque (PTPRN2), and kidney function (CDH23, HPCAL1), among others. Mendelian randomization analyses supported a causal effect of DNA methylation on incident CHD; these CpGs map to active regulatory regions proximal to long non-coding RNA transcripts. Conclusion: Methylation of blood-derived DNA is associated with risk of future CHD across diverse populations and may serve as an informative tool for gaining further insight on the development of CHD.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3